395 related articles for article (PubMed ID: 20357103)
1. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
2. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
Soto C; Estrada L; Castilla J
Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
[TBL] [Abstract][Full Text] [Related]
3. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
4. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
5. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
6. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
7. Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance.
Zhu C; Schwarz P; Abakumova I; Aguzzi A
PLoS One; 2015; 10(12):e0144983. PubMed ID: 26658276
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
9. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
10. Prions: generation and spread versus neurotoxicity.
Halliday M; Radford H; Mallucci GR
J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
[TBL] [Abstract][Full Text] [Related]
11. Cell-free amplification of prions: Where do we stand?
Cazzaniga FA; De Luca CMG; Bistaffa E; Consonni A; Legname G; Giaccone G; Moda F
Prog Mol Biol Transl Sci; 2020; 175():325-358. PubMed ID: 32958239
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.
Price DL; Borchelt DR; Sisodia SS
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6381-4. PubMed ID: 8101988
[TBL] [Abstract][Full Text] [Related]
13. Protein misfolding detected early in pathogenesis of transgenic mouse model of Huntington disease using amyloid seeding assay.
Gupta S; Jie S; Colby DW
J Biol Chem; 2012 Mar; 287(13):9982-9989. PubMed ID: 22187438
[TBL] [Abstract][Full Text] [Related]
14. Infectious prions do not induce Aβ deposition in an in vivo seeding model.
Rasmussen J; Krasemann S; Altmeppen H; Schwarz P; Schelle J; Aguzzi A; Glatzel M; Jucker M
Acta Neuropathol; 2018 Jun; 135(6):965-967. PubMed ID: 29663066
[No Abstract] [Full Text] [Related]
15. Aβ seeds and prions: How close the fit?
Rasmussen J; Jucker M; Walker LC
Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer disease: a tale of two prions.
Nussbaum JM; Seward ME; Bloom GS
Prion; 2013; 7(1):14-9. PubMed ID: 22965142
[TBL] [Abstract][Full Text] [Related]
17. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
18. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.
Walker LC; Schelle J; Jucker M
Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270558
[TBL] [Abstract][Full Text] [Related]
19. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
Moreno-Gonzalez I; Soto C
Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
[TBL] [Abstract][Full Text] [Related]
20. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
